Simplex Trading’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $3.38M | Buy |
6,700
+3,100
| +86% | +$1.64M | ﹤0.01% | 1484 |
|
|
2026
Q2 | $1.93M | Sell |
3,600
-600
| -14% | -$307K | ﹤0.01% | 2076 |
|
|
2026
Q1 | $2.2M | Buy |
+4,200
| New | +$2.01M | ﹤0.01% | 1749 |
|
|
2025
Q4 | – | Sell |
-13,800
| Closed | -$6.33M | – | 9436 |
|
|
2025
Q3 | $6.33M | Buy |
13,800
+8,600
| +165% | +$3.21M | ﹤0.01% | 1268 |
|
|
2025
Q2 | $1.57M | Sell |
5,200
-3,800
| -42% | -$1.13M | ﹤0.01% | 2326 |
|
|
2025
Q1 | $2.98M | Buy |
9,000
+1,300
| +17% | +$427K | ﹤0.01% | 1667 |
|
|
2024
Q4 | $2.38M | Sell |
7,700
-400
| -5% | -$113K | ﹤0.01% | 2038 |
|
|
2024
Q3 | $1.72M | Sell |
8,100
-3,200
| -28% | -$819K | ﹤0.01% | 2410 |
|
|
2024
Q2 | $3.16M | Sell |
11,300
-11,300
| -50% | -$2.69M | ﹤0.01% | 1787 |
|
|
2024
Q1 | $6.04M | Buy |
22,600
+14,200
| +169% | +$3.35M | ﹤0.01% | 1462 |
|
|
2023
Q4 | $1.94M | Sell |
8,400
-6,800
| -45% | -$1.19M | ﹤0.01% | 2376 |
|
|
2023
Q3 | $2.22M | Sell |
15,200
-10,700
| -41% | -$2.01M | ﹤0.01% | 1985 |
|
|
2023
Q2 | $5.98M | Buy |
25,900
+5,500
| +27% | +$1.49M | ﹤0.01% | 1198 |
|
|
2023
Q1 | $4.94M | Sell |
20,400
-22,500
| -52% | -$6.13M | ﹤0.01% | 1315 |
|
|
2022
Q4 | $12.5M | Buy |
42,900
+36,600
| +581% | +$3.58M | 0.01% | 757 |
|
|
2022
Q3 | $409K | Buy |
6,300
+2,400
| +62% | +$167K | ﹤0.01% | 3699 |
|
|
2022
Q2 | $279K | Sell |
3,900
-3,500
| -47% | -$257K | ﹤0.01% | 4186 |
|
|
2022
Q1 | $726K | Buy |
7,400
+4,700
| +174% | +$396K | ﹤0.01% | 3343 |
|
|
2021
Q4 | $228K | Buy |
2,700
+2,500
| +1,250% | +$205K | ﹤0.01% | 4996 |
|
|
2021
Q3 | $19K | Hold |
200
| – | – | ﹤0.01% | 8481 |
|
|
2021
Q2 | $19K | Buy |
200
+198
| +9,900% | +$23.4K | ﹤0.01% | 8630 |
|
|
2021
Q1 | $23K | Hold |
2
| – | – | ﹤0.01% | 7345 |
|
|
2020
Q4 | $22K | Sell |
2
-156
| -99% | -$19.1K | ﹤0.01% | 6914 |
|
|
2020
Q3 | $1.88M | Sell |
158
-70
| -31% | -$7.6K | ﹤0.01% | 1598 |
|
|
2020
Q2 | $2.58M | Sell |
228
-46
| -17% | -$4.52K | ﹤0.01% | 1311 |
|
|
2020
Q1 | $1.83M | Buy |
274
+89
| +48% | +$7.42K | ﹤0.01% | 1349 |
|
|
2019
Q4 | $1.68M | Buy |
185
+98
| +113% | +$9.5K | ﹤0.01% | 1629 |
|
|
2019
Q3 | $750K | Buy |
87
+19
| +28% | +$1.78K | ﹤0.01% | 2232 |
|
|
2019
Q2 | $712K | Sell |
68
-122
| -64% | -$13.1K | ﹤0.01% | 2240 |
|
|
2019
Q1 | $2.38M | Buy |
190
+130
| +217% | +$16.2K | 0.01% | 1218 |
|
|
2018
Q4 | $676K | Buy |
60
+27
| +82% | +$4.18K | ﹤0.01% | 1954 |
|
|
2018
Q3 | $706K | Buy |
+33
| New | +$8.28K | ﹤0.01% | 2256 |
|
|
2016
Q1 | – | Hold |
0
| – | -$8K | – | 5958 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3508 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 3739 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 3525 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 3362 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 2659 |
|
Other funds holding MDGL
Simplex Trading's MDGL Position: Q3 2026 in Review
Simplex Trading opened a new position in Madrigal Pharmaceuticals (MDGL) in Q3 2026: 3,751 shares worth $1.89M. The stake represents ﹤0.01% of the portfolio and ranks #2054 among its holdings. This is a return to the name: Simplex Trading previously reported a position in MDGL as recently as Q3 2024.
Simplex Trading first reported a position in MDGL in Q4 2014 and has held it in 29 quarters since. The position peaked at $5.23M in Q2 2023. 226 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- Simplex Trading held 3,751 shares of Madrigal Pharmaceuticals worth $1.89M as of Q3 2026.
- Madrigal Pharmaceuticals was a new Simplex Trading position in Q3 2026.
- Madrigal Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #2054 holding.
- Simplex Trading first reported a position in Madrigal Pharmaceuticals in Q4 2014 and has held it in 29 quarters since.
- Simplex Trading's Madrigal Pharmaceuticals position peaked at $5.23M in Q2 2023.
- 226 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.